Divi's Laboratories (NSE:DIVISLAB) 5-Year EBITDA Growth Rate : 6.90% (As of Dec. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories 5-Year EBITDA Growth Rate?

Divi's Laboratories's EBITDA per Share for the three months ended in Dec. 2024 was ₹31.10.

During the past 12 months, Divi's Laboratories's average EBITDA Per Share Growth Rate was 38.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -4.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Divi's Laboratories was 61.00% per year. The lowest was -62.30% per year. And the median was 12.95% per year.

Competitive Comparison of Divi's Laboratories's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Divi's Laboratories's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Divi's Laboratories's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Divi's Laboratories 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Divi's Laboratories (NSE:DIVISLAB) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Divi's Laboratories 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

532488:India

Address

Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032

Website

https://www.divislabs.com

Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines